IL178120A0 - Therapeutic combination for treatment of alzheimers disease - Google Patents
Therapeutic combination for treatment of alzheimers diseaseInfo
- Publication number
- IL178120A0 IL178120A0 IL178120A IL17812006A IL178120A0 IL 178120 A0 IL178120 A0 IL 178120A0 IL 178120 A IL178120 A IL 178120A IL 17812006 A IL17812006 A IL 17812006A IL 178120 A0 IL178120 A0 IL 178120A0
- Authority
- IL
- Israel
- Prior art keywords
- treatment
- therapeutic combination
- alzheimers disease
- alzheimers
- disease
- Prior art date
Links
- 208000024827 Alzheimer disease Diseases 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US56214104P | 2004-04-14 | 2004-04-14 | |
| PCT/IB2005/000923 WO2005099823A1 (en) | 2004-04-14 | 2005-04-04 | Therapeutic combination for treatment of alzheimers disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL178120A0 true IL178120A0 (en) | 2006-12-31 |
Family
ID=34963723
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL178120A IL178120A0 (en) | 2004-04-14 | 2006-09-14 | Therapeutic combination for treatment of alzheimers disease |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1737539A1 (enExample) |
| JP (1) | JP2007532624A (enExample) |
| KR (1) | KR20060133008A (enExample) |
| CN (1) | CN1960781A (enExample) |
| AU (1) | AU2005232447A1 (enExample) |
| BR (1) | BRPI0509881A (enExample) |
| CA (1) | CA2562069A1 (enExample) |
| IL (1) | IL178120A0 (enExample) |
| MX (1) | MXPA06011969A (enExample) |
| NO (1) | NO20065196L (enExample) |
| RU (1) | RU2006136361A (enExample) |
| TW (1) | TW200533341A (enExample) |
| WO (1) | WO2005099823A1 (enExample) |
| ZA (1) | ZA200608239B (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI432195B (zh) | 2007-10-03 | 2014-04-01 | Kowa Co | 神經細胞死亡抑制劑 |
| CA3012415C (en) * | 2016-02-11 | 2024-03-12 | Sigmathera Sas | Igmesine for use in the treatment of neurodegenerative diseases |
| DK3982956T3 (da) * | 2019-06-14 | 2024-07-22 | Joshua O Atiba | Tredobbelt farmaceutisk sammensætning til proteinholdig infektion |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020028826A1 (en) * | 2000-06-15 | 2002-03-07 | Robl Jeffrey A. | HMG-CoA reductase inhibitors and method |
| ATE331523T1 (de) * | 2002-04-02 | 2006-07-15 | Janssen Pharmaceutica Nv | Statin-therapie zur verbesserung der aufrechterhaltung der kognitiven funktion |
| WO2004034963A2 (en) * | 2002-05-17 | 2004-04-29 | Eisai Co., Ltd. | Methods and compositions using cholinesterase inhibitors |
| EP1581203A1 (en) * | 2002-12-24 | 2005-10-05 | Neurochem (International) Limited | Therapeutic formulations for the treatment of beta-amyloid related diseases |
| WO2004071431A2 (en) * | 2003-02-05 | 2004-08-26 | Myriad Genetics, Inc. | Method and composition for treating neurodegenerative disorders |
| KR20050115279A (ko) * | 2003-03-19 | 2005-12-07 | 아레스 트레이딩 에스.에이. | 알츠하이머병과 치매 질환의 치료를 위하여 단독으로 또는다른 치료제와 공동으로 이용되는 ｉｆｎ-베타 |
| US20050090449A1 (en) * | 2003-05-13 | 2005-04-28 | Boehringer Ingelheim International Gmbh | Novel statine derivatives for the treatment of Alzheimer's disease |
-
2005
- 2005-04-04 JP JP2007507862A patent/JP2007532624A/ja not_active Withdrawn
- 2005-04-04 CN CNA2005800173902A patent/CN1960781A/zh active Pending
- 2005-04-04 KR KR1020067021174A patent/KR20060133008A/ko not_active Ceased
- 2005-04-04 AU AU2005232447A patent/AU2005232447A1/en not_active Abandoned
- 2005-04-04 CA CA002562069A patent/CA2562069A1/en not_active Abandoned
- 2005-04-04 RU RU2006136361/15A patent/RU2006136361A/ru not_active Application Discontinuation
- 2005-04-04 EP EP05718393A patent/EP1737539A1/en not_active Withdrawn
- 2005-04-04 MX MXPA06011969A patent/MXPA06011969A/es unknown
- 2005-04-04 WO PCT/IB2005/000923 patent/WO2005099823A1/en not_active Ceased
- 2005-04-04 BR BRPI0509881-5A patent/BRPI0509881A/pt not_active IP Right Cessation
- 2005-04-13 TW TW094111657A patent/TW200533341A/zh unknown
-
2006
- 2006-09-14 IL IL178120A patent/IL178120A0/en unknown
- 2006-10-03 ZA ZA200608239A patent/ZA200608239B/en unknown
- 2006-11-13 NO NO20065196A patent/NO20065196L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA06011969A (es) | 2006-12-15 |
| WO2005099823A1 (en) | 2005-10-27 |
| NO20065196L (no) | 2007-01-03 |
| CA2562069A1 (en) | 2005-10-27 |
| EP1737539A1 (en) | 2007-01-03 |
| ZA200608239B (en) | 2008-06-25 |
| BRPI0509881A (pt) | 2007-10-16 |
| AU2005232447A1 (en) | 2005-10-27 |
| TW200533341A (en) | 2005-10-16 |
| RU2006136361A (ru) | 2008-04-20 |
| JP2007532624A (ja) | 2007-11-15 |
| KR20060133008A (ko) | 2006-12-22 |
| CN1960781A (zh) | 2007-05-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL227841A0 (en) | Dihydropyridinones for the treatment of cancer | |
| SG10201912182UA (en) | Improved modalities for the treatment of degenerative diseases of the retina | |
| AP2006003671A0 (en) | Sulfonamide derivatives for the treatment of diseases | |
| AP2006003669A0 (en) | Sulfonamide derivatives for the treatment of diseases | |
| TWI372056B (en) | Novel medicament combinations for the treatment of respiratory diseases | |
| GB0410399D0 (en) | The treatment of respiratory disease | |
| IL178815A0 (en) | The treatment of respiratory disease | |
| GB0320238D0 (en) | Treatment of disease | |
| GB0400802D0 (en) | Compounds for the treatment of disease | |
| EP1768656A4 (en) | TREATMENT OF OCULAR DISEASES | |
| IL178120A0 (en) | Therapeutic combination for treatment of alzheimers disease | |
| TWI350753B (en) | 1-[2h-1-benzopyran-2-one-8-yl]-piperazine derivatives for the treatment of pain | |
| GB0425854D0 (en) | Therapeutic treatment | |
| EP2059238A4 (en) | THERAPEUTIC COMPOUNDS FOR DISEASES AND DISORDERS | |
| GB0428218D0 (en) | Medicament for Treatment of Inflammatory Diseases | |
| GB0408752D0 (en) | Therapeutic treatment | |
| EP1846013A4 (en) | TREATMENT OF SKIN DISEASES | |
| ZA200606780B (en) | Compounds for the treatment of diseases | |
| AP2006003728A0 (en) | Compounds for treatment of diseases | |
| GB0415352D0 (en) | Compounds for the treatment of disease | |
| GB0407710D0 (en) | Treatment of diseases | |
| GB0420867D0 (en) | Compounds for the treatment of diseases | |
| GB0425073D0 (en) | Compounds for the treatment of diseases | |
| GB0520152D0 (en) | Treatment of respiratory disease | |
| GB0405805D0 (en) | Therapeutic treatment for tinnitus |